IDIBELL participates in a study aimed to reduce the likelihood of liver failure in older transplant donors

by Hospital Universitari de Bellvitge

Liver transplant is the only curative treatment for acute liver failure and end-stage liver disease. Since its main limitation is the scarcity of available organs, a major effort has been made in rece...

Read more

The Pediatric Orthopaedic Surgery and Traumatology team performs a meniscus transplant on an adolescent

by Fundació Sant Joan de Déu

The SJD Barcelona Children's Hospital has performed a very rare and highly specialised technique in paediatrics to reverse the deterioration of the joint that a meniscectomy performed years ago had ca...

Read more

New method to boost supply of life-saving stem cells

by Centre for Genomic Regulation

Researchers at the Centre for Genomic Regulation (CRG) in Barcelona and Columbia University in New York City have identified a protein that is critical for the expansion of typically scarce, life-savi...

Read more

Retinal transplant boost opens door to treat eyesight loss

by Centre for Genomic Regulation

Degenerating retina transplanted with stem cells expressing Ccr5 and Cxcr6. Green are the transplanted cells, red and magenta are retinal neurons. Credit: Martina Pesaresi

Read more

Researchers identify a fundamental protein to guarantee liver regeneration

by Universitat de Barcelona

Researchers from the Faculty of Medicine of the University of Barcelona and the CELLEX Biomedical Research Centre from IDIBAPS, in collaboration with scientists from the University of Sydney, Universi...

Read more

Researchers from IDIVAL have studied antibiotic-resistant bacteria isolated in transplanted patients

by Instituto de Investigación Marqués de Valdecilla

Patients with solid organ transplants, due to the transplant process itself, hospital admission and immunosuppression, among other factors, are frequently colonized or infected by antibiotic resistant...

Read more

TRANSPLANT BIOMEDICALS announces positive interim results of the first in human clinical study VIVIAN® device in kidney transplantation (the EMERGE study)

by Transplant Biomedicals

​TRANSPLANT BIOMEDICALS, a company specializing in the research and development of medical devices for organ, tissue and cell preservation, today announces the positive interim results at 30-days po...

Read more

Transplant biomedicals announces completion of patient enrolment in the emerge trial: a first in human clinical study of VIVIAN® device in kidney transplantation

by Transplant Biomedicals

TRANSPLANT BIOMEDICALS, a company specializing in the research and development of medical devices for organ, tissue and cell preservation, today announces that it has completed patient enrolment of it...

Read more

3P Biopharmaceuticals enters into a new manufacturing agreement with the Dutch Biotech Company Xenikos

by 3P Biopharmaceuticals

3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Dutch biotech company Xenikos B. V. (Xeni...

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Photos Stream